Species-Specific Difference in Antimicrobial Susceptibility Among Viridans Group Streptococci

被引:38
|
作者
Chun, Sejong [1 ]
Huh, Hee Jae [1 ]
Lee, Nam Yong [1 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul 135710, South Korea
关键词
Viridans streptococci; Penicillin; Resistance; Microbial; IN-VITRO ACTIVITIES; PENICILLIN-RESISTANT; HEMOLYTIC STREPTOCOCCI; NEUTROPENIC PATIENTS; PNEUMONIAE; IDENTIFICATION; ANTIBIOTICS; INFECTIONS; BACTEREMIA; CHILDREN;
D O I
10.3343/alm.2015.35.2.205
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Viridans group streptococci (VGS) are both commensal microbes and potential pathogens. Increasing resistance to penicillin in VGS is an ongoing issue in the clinical environment. We investigated the difference in susceptibility and resistance to penicillin among various VGS species. Methods: In total 1,448 VGS isolated from various clinical specimens were analyzed over a two-yr period. Identification and antimicrobial susceptibility test was performed by the automated VITEK 2 system (bioMerieux, France) or the Micro Scan MICroSTREP system (Siemens, Germany). Results: Among the 1,448 isolates, 412 were isolated from blood (28.4%). Streptococcus mitis group was the most frequently isolated (589 isolates, 40.7%), followed by the Streptococcus anginosus group (290 isolates, 20.0%), Streptococcus sanguinis group (179 isolates, 12.4%) and Streptococcus salivarius group (57 isolates, 3.9%). In total, 314 isolates could not be identified up to the species level. The overall non-susceptibility to penicillin was observed to be 40.0% (resistant, 11.2% and intermediately resistant, 28.8%) with uneven distribution among groups; 40.2% in Streptococcus sanguinis group (resistant, 5.0% and intermediately resistant, 35.2%), 60.3% in Streptococcus mitis group (resistant, 20.9% and intermediately resistant, 39.4%), 78.9% in Streptococcus salivarius group (resistant, 8.8% and intermediately resistant, 70.1%), and 6.2% in Streptococcus anginosus group (resistant, 1.7% and intermediately resistant, 4.5%). Conclusions: Antimicrobial resistance patterns towards penicillin show differences among various VGS; this should be considered while devising an effective antimicrobial treatment against VGS.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 50 条
  • [31] Susceptibility, Resistance and Treatment Strategy for Infections Caused by Viridans Group Streptococci - A Review
    Dhotre, Shree V.
    Jahagirdar, Vilas L.
    Davane, Milind S.
    Nagoba, Basavraj S.
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2016, 5 (04) : 1 - 9
  • [32] Antimicrobial resistance of community-acquired bloodstream isolates of viridans group streptococci
    Yap, R. L.
    Mermel, L. A.
    Maglio, J.
    INFECTION, 2006, 34 (06) : 339 - 341
  • [33] Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America
    Diekema, DJ
    Beach, ML
    Pfaller, MA
    Jones, RN
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (03) : 152 - 157
  • [34] Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents
    Smith, A
    Jackson, MS
    Kennedy, H
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (04) : 259 - 263
  • [35] Identification and antimicrobial susceptibility of viridans streptococci isolated from blood cultures in Leipzig, Germany
    Friedrichs, C.
    Fickweiler, K.
    Nitsche-Schmitz, P.
    Chhatwal, S.
    Rodloff, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S263 - S263
  • [36] Bacteremia due to viridans group streptococci with diminished susceptibility to levofloxacin among neutropenic patients receiving levofloxacin prophylaxis
    Razonable, RR
    Litzow, MR
    Khaliq, Y
    Piper, KE
    Rouse, MS
    Patel, R
    CLINICAL INFECTIOUS DISEASES, 2002, 34 (11) : 1469 - 1474
  • [37] Viridans streptococci bacteremia in children with malignancy: Relevance of species identification and penicillin susceptibility
    Husain, E
    Whitehead, S
    Castell, A
    Thomas, EE
    Speert, DP
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (06) : 563 - 566
  • [38] Antimicrobial susceptibility profiles of oropharyngeal viridans group streptococci isolates from cystic fibrosis and non-cystic fibrosis patients
    Alvarez, M
    Alvarez, ME
    Maiz, L
    Asensio, A
    Baquero, F
    Canton, R
    MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1998, 4 (02): : 123 - 128
  • [39] ANTIMICROBIAL SUSCEPTIBILITY OF GROUP D HEMOLYTIC STREPTOCOCCI (ENTEROCOCCI)
    SIMON, HJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1967, 253 (01): : 14 - &
  • [40] Penicillin Susceptibility of Viridans Group Streptococci Isolated from the Oropharynx of Patients with Hematological Malignancy
    Sayin-Kutlu, Selda
    Okke, Demet
    Demir, Melek
    Tepeli, Ebru
    Sari, Ismail
    KLIMIK JOURNAL, 2012, 25 (01) : 6 - 9